24 Followers on Owler
Jazz Pharmaceuticals, Inc CEO: undefined undefined

CEO

Add

CEO Approval Rating

- -/100

Add Founded Year

PrivateIndependent Company

Add Industry
Add Sector
Est. Annual Revenue
<$1M
Agree?
Est. Employees
<10
Agree?
Funding
$0

News

Nov 03, 2022
PR Newswire
Press Release: Jazz Pharmaceuticals, Inc : Jazz Pharmaceuticals to Present Data at 2022 ASH Meeting Showcasing Commitment to Advancing Oncology Research
Apr 20, 2022
PR Newswire
Press Release: Jazz Pharmaceuticals, Inc : Jazz Pharmaceuticals to Report 2022 First Quarter Financial Results on May 4, 2022
Mar 25, 2022
CFN Media Group
Jazz Pharmaceuticals, Inc: Jazz Pharmaceuticals Announces Significant New Investment in UK Manufacturing
May 26, 2021
PR Newswire
Press Release: Jazz Pharmaceuticals, Inc : Jazz Pharmaceuticals to Participate in Jefferies Virtual Healthcare Conference on June 2, 2021
Apr 20, 2021
centralcharts
Press Release: Jazz Pharmaceuticals, Inc : Jazz Pharmaceuticals Presents Phase 3 Study Results of Xywav (calcium, magnesium, potassium, and sodium oxybates) Oral Solution in Adult Patients with Idiopathic Hypersomnia at 2021 American Academy of Neurology Annual Meeting
Jul 13, 2020
MarketScreener
Jazz Pharmaceuticals, Inc: Jazz Pharmaceuticals : National Comprehensive Cancer Network adds Zepzelca (lurbinectedin) to Clinical Practice Guidelines in Oncology
Jun 16, 2020
centralcharts
Press Release: Jazz Pharmaceuticals, Inc : PharmaMar Announces the U.S. FDA Approval of lurbinectedin (Zepzelca ) for the Treatment of Metastatic Small Cell Lung Cancer
Feb 11, 2020
PR Newswire
Press Release: Jazz Pharmaceuticals, Inc : Jazz Pharmaceuticals to Report 2019 Fourth Quarter and Full Year Financial Results on February 25, 2020
Jan 06, 2020
PR Newswire
Press Release: Jazz Pharmaceuticals, Inc : Jazz Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference
Oct 22, 2019
PR Newswire
Press Release: Jazz Pharmaceuticals, Inc : Jazz Pharmaceuticals to Report 2019 Third Quarter Financial Results on November 5, 2019

Jazz Pharmaceuticals, Inc News

Jazz Pharmaceuticals, Inc Press Releases

Jazz Pharmaceuticals, Inc Headquarters

3170 Porter Drive

Palo Alto, California94304

+353.1.634.7800

Driving Directions »

Jazz Pharmaceuticals, Inc Summary

ABOUT

Overview

Jazz Pharmaceuticals, Inc's headquarters is located in Palo Alto, California, USA 94304. ...

Competitors

There are no competitors identified for Jazz Pharmaceuticals, Inc

Acquisitions

There have been no acquisitions found related to Jazz Pharmaceuticals, Inc

Funding

Funding data cannot be found related to Jazz Pharmaceuticals, Inc

Investments

Recent investment data cannot be found related to Jazz Pharmaceuticals, Inc

Frequently Asked Questions about Jazz Pharmaceuticals, Inc

  1. How much revenue does Jazz Pharmaceuticals, Inc generate?

    Jazz Pharmaceuticals, Inc generates $ < 1M in revenue
  2. How much funding does Jazz Pharmaceuticals, Inc have?

    Jazz Pharmaceuticals, Inc has historically raised $0 in funding
  1. Where is Jazz Pharmaceuticals, Inc's headquarters?

    Jazz Pharmaceuticals, Inc's headquarters is in Palo Alto California, USA
  2. How many employees does Jazz Pharmaceuticals, Inc have?

    Jazz Pharmaceuticals, Inc has 0 employees

Trending Companies